Jupiter Asset Management Ltd. Has $43.40 Million Stock Position in Envista Holdings Corporation $NVST

Jupiter Asset Management Ltd. grew its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 48.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,999,048 shares of the company’s stock after buying an additional 650,006 shares during the quarter. Jupiter Asset Management Ltd. owned approximately 1.22% of Envista worth $43,399,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Holocene Advisors LP bought a new stake in Envista during the 2nd quarter worth $43,936,000. Alliancebernstein L.P. grew its holdings in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in shares of Envista during the third quarter worth about $24,260,000. Integral Health Asset Management LLC acquired a new position in shares of Envista in the third quarter valued at approximately $11,204,000. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock valued at $72,726,000 after buying an additional 444,725 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on NVST shares. Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Stifel Nicolaus set a $31.00 price objective on shares of Envista in a research note on Friday, February 6th. Robert W. Baird raised their target price on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. lifted their target price on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Mizuho upped their price target on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a research report on Tuesday, February 10th. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, Envista currently has an average rating of “Hold” and a consensus target price of $28.83.

Envista Stock Up 1.8%

Shares of NYSE NVST opened at $23.74 on Friday. The company’s 50 day moving average price is $25.43 and its 200-day moving average price is $24.44. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. Envista Holdings Corporation has a 52-week low of $17.78 and a 52-week high of $30.42. The company has a market capitalization of $3.86 billion, a P/E ratio of 57.89, a price-to-earnings-growth ratio of 1.46 and a beta of 0.92.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s revenue was up 14.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts forecast that Envista Holdings Corporation will post 1.43 earnings per share for the current year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.